* The English version of this report will be published at a later date.

Health and Global Policy Institute (HGPI) conducted a nationwide survey on cancer in February 2026, targeting 10,000 men and women aged 20 years and over across Japan.
Since 2005, shortly after its establishment, HGPI has continuously conducted surveys and policy advocacy activities on the state of cancer care and health policy, focusing on what patients and citizens expect.

As Japan marks 20 years since the enactment of the Cancer Control Act in 2006, the societal conditions and the environment surrounding healthcare have undergone significant changes. In this context, advancing cancer care in the right direction requires not only the perspectives of patients and those affected, but also broader societal discussions including the sustainability of the healthcare delivery system and the social security system.
Against this backdrop, this survey was conducted with the aim of examining the future direction of the healthcare system surrounding cancer from multiple perspectives, targeting citizens including cancer patients and those affected. This survey covers a wide range of topics, including: knowledge of cancer treatment, attitudes toward the centralization of medical functions, participation in cancer screening, perceptions of cancer genomic medicine, and perceptions of medical costs and the healthcare system.

[Survey Overview]

• Target: Men and women aged 20 years and over residing in Japan
• Survey Method: Online survey
• Valid Responses: 10,000
• Survey Period: February 2026
• Sampling Method: Adjusted by region, age group, and gender

* This survey was conducted with a broad range of respondents to visualize the awareness and expectations of citizens, including cancer patients and those affected. Therefore, prior cancer experience was not set as a condition for sampling. Among respondents, 9% had a history of cancer themselves, approximately 35% had a family member within the second degree with a history of cancer, and approximately 38% had either a personal or family history of cancer.